Pharmaceuticals

Companies attract venture funding for redesigned psychedelic drugs

As the patents on various weight-loss drugs near expiration, companies in India and China are vying to make lower-cost versions that will widen access to such treatments

The drug donanemab slows progression of symptoms in people with early stages of Alzheimer’s disease, but questions linger about the durability of its effect

Most pregnant people take prenatal supplements, but weak regulation means these products don’t necessarily provide the needed nutrients

Scientific advisers vote overwhelmingly that the risks of MDMA treatment for post-traumatic stress disorder outweigh the benefits

Semaglutide, the same compound in obesity drug Wegovy, slashes risk of kidney failure and death for people with type 2 diabetes

People may someday have a surprisingly familiar tool to prevent viral infections: one of the antibiotics found in a common ointment

As climate change brings more intense heat waves, scientists are trying to understand how certain medications interact with the body’s thermoregulation system

Many researchers think that Wegovy and Ozempic should be taken for life, but myriad factors can force people off the drugs

A recent study suggests that Paxlovid is ineffective at treating symptoms in people with mild illness or those who have been fully vaccinated. It is still a lifesaving medication in vulnerable groups

Benadryl, which contains diphenhydramine, is a drugstore mainstay and just one medication out of many that could possibly damage brain health

The FDA recently approved semaglutide (Wegovy) for preventing serious heart conditions in some people, but questions remain about how it works